MEDS

DataMeds AI, Inc. Common Stock

1.18

USD

-0.04

-3.28%

Nov 06, 15:59 UTC -5

Closed

After-Market

1.19

+0.01

+1.10%

DataMeds AI, Inc. Common Stock (MEDS) Earnings

MEDS Earnings Reports

Positive Surprise Ratio

MEDS beat 2 of 2 last estimates.

100%

Next Report

Date of Next Report

Nov 18, 2026

Estimate for Q3 26 (Revenue/ EPS)

Implied change from Q2 26 (Revenue/ EPS)

Implied change from Q3 25 (Revenue/ EPS)

DataMeds AI, Inc. Common Stock earnings per share and revenue

On Aug 17, 2026, MEDS reported earnings of -- USD per share (EPS) for Q2 26, -- the estimate of -0.23 USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference.

Looking ahead to Q3 26, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Nyxoah SA Ordinary Shares

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.30

Actual

-$0.17

Surprise

+42.29%

10x Genomics, Inc. Class A Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.26

Actual

-$0.15

Surprise

+43.35%

Doximity, Inc.

Report Date

Nov 05, 2026 For Q2 27

Estimate

$0.35

Actual

$0.36

Surprise

+0.56%

iRhythm Holdings, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

$0.06

Actual

$0.82

Surprise

+1,214.10%

Privia Health Group, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

$0.09

Actual

$0.10

Surprise

+3.73%

Schrodinger, Inc. Common Stock

Report Date

Nov 04, 2026 For Q3 26

Estimate

-$0.70

Actual

-$0.50

Surprise

+29.57%

Enovis Corporation

Report Date

Nov 05, 2026 For Q3 26

Estimate

$0.78

Actual

$0.88

Surprise

+12.07%

Evolent Health, Inc Class A Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

$0.05

Actual

$0.06

Surprise

+13.21%

Fulgent Genetics, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.66

Actual

-$0.09

Surprise

+86.43%

Health Catalyst, Inc Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.04

Actual

-$0.03

Surprise

+38.14%

FAQ

What were DataMeds AI, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, DataMeds AI, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, 0% as expectations.

How did the market react to DataMeds AI, Inc. Common Stock's Q2 2026 earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is DataMeds AI, Inc. Common Stock expected to report next?

The next earning report is scheduled for Nov 18, 2026.

What are the forecasts for DataMeds AI, Inc. Common Stock's next earnings report?

Based on -- analysts, DataMeds AI, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q3 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.